Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRST: Ferumoxytol vs Iron Sucrose in CKD
NCT01052779Phase 2Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Mar 2010
- Primary completion
- Jul 2011
- Modality
- Nanoparticles, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Mar 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01052779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052779.